OmniAb (OABI) Competitors $3.92 +0.07 (+1.82%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends OABI vs. CORS, DTRT, GWII, WRAC, IQMD, UPBD, DFIN, STER, XMTR, and NVEEShould you be buying OmniAb stock or one of its competitors? The main competitors of OmniAb include Corsair Partnering (CORS), DTRT Health Acquisition (DTRT), Good Works II Acquisition (GWII), Williams Rowland Acquisition (WRAC), Intelligent Medicine Acquisition (IQMD), Upbound Group (UPBD), Donnelley Financial Solutions (DFIN), Sterling Check (STER), Xometry (XMTR), and NV5 Global (NVEE). OmniAb vs. Corsair Partnering DTRT Health Acquisition Good Works II Acquisition Williams Rowland Acquisition Intelligent Medicine Acquisition Upbound Group Donnelley Financial Solutions Sterling Check Xometry NV5 Global OmniAb (NASDAQ:OABI) and Corsair Partnering (NYSE:CORS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment, valuation, dividends and community ranking. Do insiders & institutionals believe in OABI or CORS? 72.1% of OmniAb shares are held by institutional investors. Comparatively, 80.1% of Corsair Partnering shares are held by institutional investors. 8.6% of OmniAb shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has more volatility & risk, OABI or CORS? OmniAb has a beta of -0.12, indicating that its stock price is 112% less volatile than the S&P 500. Comparatively, Corsair Partnering has a beta of 0.02, indicating that its stock price is 98% less volatile than the S&P 500. Does the MarketBeat Community believe in OABI or CORS? OmniAb received 23 more outperform votes than Corsair Partnering when rated by MarketBeat users. CompanyUnderperformOutperformOmniAbOutperform Votes23100.00% Underperform VotesNo VotesCorsair PartneringN/AN/A Which has higher valuation & earnings, OABI or CORS? Corsair Partnering has lower revenue, but higher earnings than OmniAb. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOmniAb$34.16M13.56-$50.62M-$0.62-6.32Corsair PartneringN/AN/A$13.19MN/AN/A Do analysts prefer OABI or CORS? OmniAb presently has a consensus price target of $9.00, indicating a potential upside of 129.59%. Given OmniAb's stronger consensus rating and higher possible upside, equities analysts clearly believe OmniAb is more favorable than Corsair Partnering.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OmniAb 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Corsair Partnering 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is OABI or CORS more profitable? Corsair Partnering has a net margin of 0.00% compared to OmniAb's net margin of -308.78%. OmniAb's return on equity of -20.97% beat Corsair Partnering's return on equity.Company Net Margins Return on Equity Return on Assets OmniAb-308.78% -20.97% -18.05% Corsair Partnering N/A -80.72%3.55% Does the media refer more to OABI or CORS? In the previous week, Corsair Partnering had 1 more articles in the media than OmniAb. MarketBeat recorded 1 mentions for Corsair Partnering and 0 mentions for OmniAb. Corsair Partnering's average media sentiment score of 0.00 beat OmniAb's score of -0.26 indicating that Corsair Partnering is being referred to more favorably in the news media. Company Overall Sentiment OmniAb Neutral Corsair Partnering Neutral SummaryOmniAb and Corsair Partnering tied by winning 7 of the 14 factors compared between the two stocks. Ad Porter & CompanyThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. Get OmniAb News Delivered to You Automatically Sign up to receive the latest news and ratings for OABI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OABI vs. The Competition Export to ExcelMetricOmniAbCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$463.19M$4.31B$5.38B$8.84BDividend YieldN/A1.65%5.13%4.09%P/E Ratio-6.3257.60105.1417.83Price / Sales13.5656.181,233.15158.41Price / CashN/A23.4240.4136.29Price / Book1.593.397.096.50Net Income-$50.62M$139.66M$119.65M$226.22M7 Day Performance1.03%2.42%2.25%4.03%1 Month Performance-0.51%19.39%-2.33%4.92%1 Year Performance-10.91%32.12%33.98%29.30% OmniAb Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OABIOmniAb1.6747 of 5 stars$3.92+1.8%$9.00+129.6%-10.9%$463.19M$34.16M-6.327CORSCorsair PartneringN/A$10.37flatN/A+0.0%$308.33MN/A0.002,021DTRTDTRT Health AcquisitionN/A$10.34-0.1%N/A+0.0%$297.28MN/A0.002,021Positive NewsGWIIGood Works II AcquisitionN/A$10.11flatN/AN/A$89.68MN/A0.002,021WRACWilliams Rowland AcquisitionN/A$10.50-0.7%N/A+0.0%$87.68MN/A0.002,021IQMDIntelligent Medicine AcquisitionN/A$11.04flatN/AN/A$64.75MN/A0.002,021UPBDUpbound Group3.9025 of 5 stars$33.80+2.5%$39.17+15.9%+15.0%$1.85B$3.99B23.3112,970DFINDonnelley Financial Solutions3.7029 of 5 stars$61.480.0%$76.33+24.2%+7.2%$1.77B$802.10M19.551,900Positive NewsHigh Trading VolumeSTERSterling Check1.3138 of 5 stars$16.74flat$16.75+0.1%N/A$1.64B$719.64M-98.475,700XMTRXometry1.7283 of 5 stars$31.40+1.1%$27.71-11.7%+54.8%$1.56B$463.41M-29.90992Positive NewsNVEENV5 Global3.0979 of 5 stars$21.50-1.4%$28.75+33.7%-12.7%$1.40B$914.19M38.394,106News Coverage Related Companies and Tools Related Companies Corsair Partnering Alternatives DTRT Health Acquisition Alternatives Good Works II Acquisition Alternatives Williams Rowland Acquisition Alternatives Intelligent Medicine Acquisition Alternatives Upbound Group Alternatives Donnelley Financial Solutions Alternatives Sterling Check Alternatives Xometry Alternatives NV5 Global Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:OABI) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OmniAb, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OmniAb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OABI with Qtrade Free OABI Stock Alerts